Andere Sprachen Cereno Scientific AB (publ) NORDIC GROWTH MARKET

Aktien

CRNO B

SE0008241558

CRNO B

Schlusskurs NORDIC GROWTH MARKET Andere Börsenplätze 00:00:00 20.06.2023			% 5 Tage	% 1. Jan.
0,521 ^SEK	-7,13 %		+7,98 %	-76,90 %

02.05.	Cereno Scientific AB (Publ) gibt die Ernennung des Nominierungsausschusses im Vorfeld der Jahreshauptversammlung 2025 bekannt	CI
16.04.	Cereno Scientific AB (Publ) stimmt der Wahl neuer Vorstandsmitglieder zu	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cereno Scientific: Nomination committee appointed ahead of annual general meeting 2025	02.05.
Cereno Scientific AB Announces Nomination Committee Appointments Ahead of Annual General Meeting 2025	02.05.
Report from Annual General Meeting 2024 of Cereno Scientific AB	16.04.
Cereno Scientific AB Approves Election of New Directors	16.04.
Cereno Scientific Secures Patent Expansion in Canada for Hypertension Drug Candidate	11.04.
Cereno Scientific expands patent protection for epigenetic HDAC inhibitor CS1:s second patent family	11.04.
Cereno Scientific Files Clinical Trial Application for Blood Cut Treatment	10.04.
Cereno Scientific submits Clinical Trial Application (CTA) for first-in-human Phase I study with novel epigenetic HDACi drug candidate CS014	10.04.
Cereno Scientific AB Submits Clinical Trial Application for First-In-Human Phase I Study with Novel Epigenetic HDACi Drug Candidate CS014	10.04.
Cereno Scientific Receives Patent Expansion in Europe	09.04.
Cereno Scientific announces extended patent protection in Europe for CS585 program	09.04.
Cereno Scientific releases Insights Video Season 3 Episode 9 with Dr. Björn Dahlöf, CSO, Cereno Scientific	03.04.
Cereno Scientific participates at the ISHLT 44th Annual meeting and Scientific sessions to expand network and meet with investigators for the Phase II Study in PAH	28.03.
Cereno Scientific releases Insights Video Season 3 Episode 8 with Björn Dahlöf, CSO, Cereno Scientific	27.03.
Cereno Scientific publishes Annual Report for 2023	26.03.
Cereno Scientific participates at the upcoming medical conference ACC.24 to further build presence in the Cardiology community	25.03.
Cereno Scientific Obtains New European Patent for Hypertension Drug Candidate	22.03.
Cereno Scientific announces new patent issued in 25 European countries for Phase II drug candidate CS1	22.03.
Cereno Scientific announces that a study protocol synopsis for the FDA approved Expanded Access Program for CS1 in PAH has been published on ClinicalTrials.gov	21.03.
Cereno Scientific Announces A Study Protocol Presented for the FDA Approved Expanded Access Program for CS1 in PAH	21.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cereno Scientific AB (publ) NORDIC GROWTH MARKET

Aktien

CRNO B

SE0008241558

CRNO B

Andere Sprachen

Filter